Latest filing published 11 Jun 2018 for Cardiff Oncology, Inc., €6,782.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -46.7%Entry US$5.16 · Close at T+365 US$2.75
- -88.6%Entry US$158.40 · Close at T+365 US$18.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stanley Tennant: trading record in brief
Filings by Stanley Tennant span 2 companies, the busiest being Cardiff Oncology, Inc. and Oak Ridge Financial Services, Inc. In total, 12 filings cover trades dated from 13 April 2012 to 8 June 2018.
The open-market side counts 7 purchases for €247k alongside 1 sale for €4,823. Taken together, the purchases exceed the sales by €243k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 3 option exercises. 2018 to date brings 2 purchases and no sales.
A typical purchase (the median) is worth €29k. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -46.4%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 13 June 2018, reports an open-market purchase of €6,782 in Cardiff Oncology, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stanley Tennant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.8011.2% of flowCommon StockSEC:0000899243-18-015835:0Canonical exit: 6 Sept 2018 (T+90)
- 16,667 shares0Common StockSEC:0000899243-18-000532:0
- 16,667 shares0Common StockSEC:0000899243-18-000487:0
- 8,334 shares@ US$0.698.0% of flowCommon StockSEC:0001104659-17-055831:0
- 8,484 shares0Common StockSEC:0001104659-17-055900:0
- 14,966 shares@ US$2.0047.5% of flowCommon StockSEC:0001104659-16-162687:0Canonical exit: 16 Mar 2017 (T+90)
- 10,000 shares@ US$2.1033.3% of flowCommon StockSEC:0001104659-16-162837:0Canonical exit: 19 Mar 2017 (T+90)
- 10,000 shares@ US$6.06Common StockSEC:0001104659-15-059136:0Canonical exit: 10 Nov 2015 (T+90)
- 25,000 shares@ US$4.82Common StockSEC:0001104659-12-081347:0Canonical exit: 28 Feb 2013 (T+90)
- 100,000 shares@ US$0.50Common StockSEC:0001104659-12-025723:0Canonical exit: 12 Jul 2012 (T+90)
10 of 10 declarations